SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syncom Formulations awarded by INDIA 5000 BEST MSME AWARDS 2021

08 Apr 2021 Evaluate

Syncom Formulations (India) has been awarded by INDIA 5000 BEST MSME AWARDS 2021 organized by Benchmark Trust for Quality Excellence, 2021 for outstanding contribution in quality & excellence, in realm of customer satisfaction, impact on society through service & management to boost up all. 

Syncom Formulations (India) is a renowned name in the Indian Pharmaceutical Industry, engaged in the business of manufacturing, selling, distribution and marketing of pharmaceuticals.

Syncom Formulations Share Price

14.14 0.13 (0.93%)
10-Jul-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1932.00
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1152.00
Lupin 2496.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: